United Kingdom

Cannabis-based products for medicinal use rescheduled by UKSI 2018/1055; no adult-use opening in primary UK legislation.

Last updated: 2018-11-01

Active market models

Medical only: Regulated medical prescription route; no adult-use retail or possession relief.
No legal market: Cannabis remains fully prohibited outside narrow research or medical exceptions.

Developments

2018-11-01 — Cannabis-based products rescheduled for medicinal use
Statutory instrument UKSI 2018/1055 reschedules cannabis-based products for medicinal use in humans.
Sources: UK legislation.gov.uk

Official sources

Misuse of Drugs (Amendments) (Cannabis and Licence Fees) Regulations 2018 (UKSI 2018/1055) — UK legislation.gov.uk — 2018-11-01

All jurisdictions · Recent legal and policy developments · Source library